/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy
Event: ESC Congress 2019
Topic: Secondary Prevention
Session: Progress in secondary prevention - New treatments
ESC 365 is supported by
